Clinical Trials for Metastatic Castration Resistant Prostate Cancer

Find clinical trials for metastatic castration resistant prostate cancer. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

NCT ID: NCT07025512

This clinical trial is studying a new treatment called 177Lu-PSMA-617 for men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bone marrow, causing low...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

NCT ID: NCT06830850

This clinical trial is designed to test a new medication called HRS-5041 for men who have metastatic castration-resistant prostate cancer, which means their cancer has spread and is no longer respo...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Sydney, , Australia, Sydney, New South Wales, Australia +10 more

A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

NCT ID: NCT04104893

This clinical trial is studying the effectiveness of a medication called pembrolizumab, which is a type of treatment known as a checkpoint inhibitor, in men with advanced prostate cancer that has n...

Recruiting

Phase: PHASE2 Type: interventional Locations: Ann Arbor, Michigan, United States, Durham, North Carolina, United States +13 more

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

NCT ID: NCT04729114

This clinical trial is investigating a new treatment called PRL-02 depot for men with advanced prostate cancer, which can be resistant to other treatments. PRL-02 depot is given through an injectio...

Recruiting

Phase: PHASE1 Type: interventional Locations: Charlottesville, Virginia, United States, Dallas, Texas, United States +27 more

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT ID: NCT06866795

This clinical trial is studying a new treatment called GT-220F for men with metastatic castration-resistant prostate cancer (mCRPC), which is a type of advanced prostate cancer that continues to gr...

Not yet recruiting

Phase: PHASE1 Type: interventional

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

NCT ID: NCT06517719

This clinical trial is studying the real-world use of a treatment called lutetium (177Lu) vipivotide tetraxetan for men with metastatic castration-resistant prostate cancer (mCRPC). This type of ca...

Recruiting

Type: observational Locations: Trier, , Germany, Ulm, , Germany +14 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions